Photo of Dr. Dr. Adem Koyuncu

Dr. Dr. Adem Koyuncu

Adem Koyuncu is double qualified as a lawyer and medical doctor and a partner in our Brussels and Frankfurt office. He is a chair of the firm's "Food, Drug & Device" practice group and also a member of our Compliance practice. Adem is recognized as a "leading lawyer for pharma and medical devices law" (JUVE).

Adem is a life sciences industry advisor with more than 25 years of professional experience. He has a broad practice that cuts across regulatory, compliance, IP, privacy and liability matters. Adem also provides strategic advice. He knows the life sciences sector also from his earlier work in the pharmaceutical industry and as a medical doctor. He represents clients before courts and authorities and assists them in contract negotiations, investigations and transactions. For years, Adem is listed in various lawyer rankings.

See some Accolades from Clients and Surveys:

"Adem Koyuncu is one of the most intelligent lawyers I know." (Legal 500 2023)
"He is one of the most detail-oriented and client-focused partners I have ever encountered." (Client, Chambers 2021)
"Great professional and human competence, good team player." (Client/Adverse Party, JUVE 2022)
"I find him to be one of the most pragmatic regulatory lawyers. He was a doctor before a lawyer, has been in-house, worked on lots of stuff that I have to handle in-house, which helps when getting advice. He is really good at saying it's a complex situation and your best option is to do this." (Chambers 2022)
"He always comes through with extremely helpful advice. He brings a unique understanding and experience to his practice as both a lawyer and medical doctor." (Chambers 2021)
"He is an excellent dispute resolution lawyer and advises at the highest level, including, in particular, strategic advice." (Legal 500 2023)
"He is very sharp and quick, while at the same time having a good sense of humor and nerves of steel. Very pleasant to work with." (Legal 500 2022)
He is described as "versatile competent, reliable and high quality" (JUVE 2021) and "incredibly fast." (JUVE 2018)
Provides advice at "an outstanding level." (Legal 500 2015)
"Very strong negotiation skills." (JUVE 2011)
Clients appreciate his "very broad knowledge and long-standing expertise" (JUVE 2021/22) and that "he is approachable, knowledgeable and really easy to talk to over the various issues. He is calm and has seen most problems before." (Chambers 2020)
Peer lawyers described him as "highly competent" and a "very good and pleasant lawyer” (JUVE 2014) and as "the off-label-guru, substantively very good, creative." (JUVE 2022)

Adem is the author of numerous publications (e.g., in leading books on pharma law, product liability and clinical trials) and frequent speaker at different events. As such, he will soon speak at following events:

“Pharma Liability and Risk Prevention," Marburg Symposium on Pharma Law 2025 (March 14, 2025)
"Risk medical device - Basics of liability and insurability," BVMed Academy, webinar (in German) (March 26, 2025)
"Risk medical device - IT security, risk management & product liability are a matter for the management!," BVMed Academy, webinar (in German) (April 28, 2025)
"Risk medical device - Challenges & limits of insurability," BVMed Academy, webinar (in German) (June 4, 2025)

Contact:Read more about Dr. Dr. Adem KoyuncuEmail

On 1 July 2024, Germany has enacted stricter requirements for the processing of health data when using cloud-computing services. The new Section 393 SGB V aims to establish a uniform standard for the use of cloud-computing services in the statutory healthcare system which covers around 90% of the German population. In this blog…

Continue Reading Germany enacts stricter requirements for the processing of Health Data using Cloud-Computing – with potential side effects for Medical Research with Pharmaceuticals and Medical Devices

On March 5, 2025, the final text of the European Health Data Space (EHDS) was published in the EU Official Journal (see here).  In April 2024,we wrote several blog posts on EHDS based on a provisional compromise text.  We have now updated those to reflect the final version and included references to the correct provisions.

This article focuses on the implications for “wellness applications” and medical devices; for an overview of the EHDS generally, see our first post in this series.Continue Reading EHDS Series – 4: The European Health Data Space’s Implications for “Wellness Applications” and Medical Devices

Digital health apps are increasingly used in practice. They raise various questions under regulatory and data protection and data security laws. On November 6, 2023, the German Conference of the Independent Data Protection Supervisory Authorities (Datenschutzkonferenz, DSK), a national body which brings together Germany’s federal and regional data protection authorities, issued a paper about the GDPR’s application to cloud-based digital health applications (“health apps”) that are not subject to the German Digital Health Applications Ordinance (Digitale Gesundheitsanwendungen-Verordnung, the “DiGA Regulation”).Continue Reading German Data Protection Authorities Publish Paper on Cloud-Based Digital Health Applications

On 3 July 2020, the German parliament passed a draft bill (German language) for patient data protection and for more digitalisation in the German healthcare system (Patientendaten-Schutz-Gesetz). The draft bill is currently in the legislative procedure and is expected to enter into force in autumn 2020.

One of…
Continue Reading Germany Prepares New Law for Patient Data Protection and Increased Digitalisation in Healthcare and for “Data Donations” for Research Purposes